<DOC>
	<DOC>NCT01558531</DOC>
	<brief_summary>The purpose of this study is to evaluate the efficacy of drug-eluting balloon angioplasty followed versus conventional balloon angioplasty in superficial femoral artery and popliteal artery re-stenosis.</brief_summary>
	<brief_title>Drug Eluting Balloon in Peripheral Intervention for In-Stent Restenosis</brief_title>
	<detailed_description />
	<mesh_term>Peripheral Arterial Disease</mesh_term>
	<mesh_term>Peripheral Vascular Diseases</mesh_term>
	<criteria>age&gt;18 years intermittent claudication (Fontane III or IV) angiographic stenosis&gt;50% or occlusion of superficial femoralpopliteal artery&gt;40mm, previously treated with nitinol stent implantation, with at least one belowknee vessel to the ankle allergy to Paclitaxel contraindication for combined antiplatelet treatment life expectancy &lt;1 year hypersensitivity or contraindication to one of the study drugs lack of consent need for amputation angiographic evidence of stent fracture</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2015</verification_date>
	<keyword>peripheral arterial disease</keyword>
	<keyword>drug-eluting balloon</keyword>
	<keyword>restenosis</keyword>
</DOC>